We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABEV icon
776
Ambev
ABEV
$47.9B
-15,200
Closed -$40K
APLT
777
DELISTED
Applied Therapeutics
APLT
-80,000
Closed -$2.89M
BAP icon
778
Credicorp
BAP
$30.5B
-95,800
Closed -$12.8M
BBVA icon
779
Banco Bilbao Vizcaya Argentaria
BBVA
$142B
-113
Closed
BWA icon
780
BorgWarner
BWA
$12.8B
-6,448
Closed -$200K
CHKP icon
781
Check Point Software Technologies
CHKP
$14.3B
$0 ﹤0.01%
+4
New +$488
CHRW icon
782
C.H. Robinson
CHRW
$20.5B
-11
Closed -$1K
CWST icon
783
Casella Waste Systems
CWST
$5.76B
-44,475
Closed -$2.32M
CYBR
784
DELISTED
CyberArk
CYBR
-10
Closed -$1K
DINO icon
785
HF Sinclair
DINO
$16.2B
-22,139
Closed -$646K
EWJ icon
786
PUT
iShares MSCI Japan ETF
EWJ
$21.2B
-620,000
Closed -$404K
GOTU icon
787
Gaotu Techedu
GOTU
$405M
-5,000
Closed -$300K
HCM icon
788
HUTCHMED
HCM
$1.96B
-35,000
Closed -$965K
NBP
789
NovaBridge Biosciences American Depositary Shares
NBP
$186M
-32,624
Closed -$977K
JAZZ icon
790
Jazz Pharmaceuticals
JAZZ
$16.1B
-10
Closed -$1K
JNPR
791
DELISTED
Juniper Networks
JNPR
-22,642
Closed -$518K
LDOS icon
792
Leidos
LDOS
$14.4B
-46,127
Closed -$4.32M
LKQ icon
793
LKQ Corp
LKQ
$6.72B
-25,665
Closed -$672K
MRNA icon
794
Moderna
MRNA
$21.6B
-285,834
Closed -$19.9M
RDY icon
795
Dr. Reddy's Laboratories
RDY
$9.8B
-70,000
Closed -$742K
REG icon
796
Regency Centers
REG
$14.9B
-11,270
Closed -$517K
RIO icon
797
Rio Tinto
RIO
$152B
-25,220
Closed -$1.42M
RL icon
798
Ralph Lauren
RL
$22.4B
-37,033
Closed -$7.88M
SLG icon
799
SL Green Realty
SLG
$3.83B
-64,273
Closed -$3.07M
TCOM icon
800
Trip.com Group
TCOM
$29B
-36,020
Closed -$934K

Similar funds

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.